Trupanion (NASDAQ:TRUP) Price Target Cut to $52.00 by Analysts at Piper Sandler

Trupanion (NASDAQ:TRUPFree Report) had its target price decreased by Piper Sandler from $57.00 to $52.00 in a report released on Thursday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the financial services provider’s stock.

Other research analysts have also issued research reports about the company. Stifel Nicolaus raised their target price on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Northland Securities lifted their price target on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Trupanion has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

Read Our Latest Stock Analysis on TRUP

Trupanion Trading Down 25.5 %

Shares of Trupanion stock opened at $35.40 on Thursday. Trupanion has a 52 week low of $19.69 and a 52 week high of $57.90. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The stock has a 50 day moving average price of $48.40 and a two-hundred day moving average price of $47.97.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.11%. The company had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Sell-side analysts forecast that Trupanion will post 0.13 earnings per share for the current year.

Insider Buying and Selling at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 9,867 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $53.08, for a total value of $523,740.36. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Emily Dreyer sold 900 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $54.55, for a total value of $49,095.00. Following the completion of the sale, the senior vice president now owns 23,808 shares in the company, valued at approximately $1,298,726.40. The trade was a 3.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,581 shares of company stock worth $615,159 over the last ninety days. 5.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Trupanion

Hedge funds have recently made changes to their positions in the stock. SBI Securities Co. Ltd. purchased a new position in shares of Trupanion in the fourth quarter valued at $25,000. Jones Financial Companies Lllp grew its position in shares of Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 238 shares in the last quarter. Quarry LP purchased a new position in shares of Trupanion in the fourth quarter valued at $39,000. Quest Partners LLC purchased a new position in shares of Trupanion in the third quarter valued at $37,000. Finally, Aster Capital Management DIFC Ltd grew its position in Trupanion by 988.5% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider’s stock worth $55,000 after buying an additional 1,028 shares in the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.